Edison Issues Update on Pixium Vision (PIX)

27 Jul, 2016, 08:15 ET from Edison Investment Research

LONDON, July 27, 2016 /PRNewswire/ --

Pixium announced on 25 July that its Iris II epi-retinal implant has received CE mark clearance from European regulatory authorities. This pivotal step helps validate the device's safety and can enable the first stage of a commercial roll-out of this device in certain European markets. Our rNPV, inclusive of net cash, is €11.62 per share (vs €10.28 previously).

     (Logo: http://photos.prnewswire.com/prnh/20130417/608168 )

Pixium Vision is a French medical device company developing retinal implants for patients with retinitis pigmentosa and macular degeneration. CE mark clearance was recently received on its initial product, Iris. A sub-retinal implant, Prima, is also being developed simultaneously.

Click here to view the full report.

All reports published by Edison are available to download free of charge from its website http://www.edisoninvestmentresearch.com.

About Edison: Edison is an international equity research firm with a team of over 110 analysts, investment and roadshow professionals and works with both large and smaller capitalised companies, blue chip institutional investors, wealth managers, private equity and corporate finance houses to support their capital markets activity. Edison provides services to more than 420 retained corporate and investor clients from offices in London, New York, Frankfurt, Sydney and Wellington. Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact: 

Pooya Hemami              
Edison Investment Research                
+1-646-653-7026

Maxim Jacobs                          
Edison Investment Research                
+1-646-653-7027
healthcare@edisongroup.com

Contact details: Learn more at http://www.edisongroup.com and connect with Edison on:  
    
LinkedIn http://www.linkedin.com/company/edison-investment-research
Twitter  http://www.twitter.com/Edison_Inv_Res
YouTube  http://www.youtube.com/edisonitv
Google+  https://plus.google.com/105425025202328783163/posts

SOURCE Edison Investment Research